{"organizations": [], "uuid": "f884cff50de94ed320c853c60c119a8b3021a085", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180221.html", "section_title": "Archive News &amp; Video for Wednesday, 21 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-the-medicines-q4-gaap-loss-per-sha/brief-the-medicines-q4-gaap-loss-per-share-2-19-from-continuing-operations-idUSASB0C6M7", "country": "US", "domain_rank": 408, "title": "BRIEF-The Medicines Q4 GAAP Loss Per Share $2.19 From Continuing Operations", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.977, "site_type": "news", "published": "2018-02-21T20:10:00.000+02:00", "replies_count": 0, "uuid": "f884cff50de94ed320c853c60c119a8b3021a085"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-the-medicines-q4-gaap-loss-per-sha/brief-the-medicines-q4-gaap-loss-per-share-2-19-from-continuing-operations-idUSASB0C6M7", "ord_in_thread": 0, "title": "BRIEF-The Medicines Q4 GAAP Loss Per Share $2.19 From Continuing Operations", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters) - medicines co", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 21 (Reuters) - Medicines Co:\n* THE MEDICINES COMPANY REPORTS FOURTH-QUARTER AND FULL-YEAR 2017 BUSINESS AND FINANCIAL RESULTS\n* Q4 GAAP LOSS PER SHARE $2.19 FROM CONTINUING OPERATIONS * Q4 REVENUE $8.6 MILLION * Q4 ADJUSTED NON-GAAP LOSS PER SHARE $0.61 FROM CONTINUING OPERATIONS\n* WORLDWIDE NET REVENUE WAS $8.6 MILLION IN Q4 OF 2017 VERSUS $17.4 MILLION IN Q4 OF 2016 Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-21T20:10:00.000+02:00", "crawled": "2018-02-22T18:01:58.000+02:00", "highlightTitle": ""}